Staar Surgical Co (NAS:STAA)

Q1 2025 STAAR Surgical Co Earnings Call Transcript

May 7, 2025 / 09:15 PM GMT

Release Date Price: $19.44 (+4.29%)

Transcript 10-Q8-K

Key Points

Positve

Staar Surgical Co (STAA) has streamlined its management structure to enhance efficiency, including promoting Warren Faust to President and COO.
The company has taken proactive steps to mitigate the impact of tariffs by negotiating consignment agreements and shipping inventory to China.
Staar Surgical Co (STAA) is focusing on cost optimization, aiming to reduce SG&A expenses to approximately $225 million by the end of 2025.
The company is expanding its manufacturing capabilities in Switzerland, which will help mitigate tariff impacts and support future growth.
Staar Surgical Co (STAA) is optimistic about the growing demand for its Evo ICL technology, particularly in China, where in-market demand is strengthening.

Negative

Staar Surgical Co (STAA) reported a significant decline in total net sales for Q1 2025, primarily due to minimal purchases by China distributors.
The company's profitability was impacted by lower sales and restructuring charges, resulting in an adjusted EBITDA loss of $26.4 million for Q1 2025.
Gross margin declined to 65.8% in Q1 2025 from 78.9% in the year-ago quarter, due to higher manufacturing costs and inventory reserves.
The company withdrew its financial outlook due to economic uncertainties and evolving tariff situations, creating uncertainty for investors.
Staar Surgical Co (STAA) faces challenges in overcoming obstacles such as patient awareness and surgeon reluctance to expand its market share.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

STAA.OQ - STAAR Surgical Co
Q1 2025 STAAR Surgical Co Earnings Call
May 07, 2025 / 09:15PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Star Surgical first quarter 2025 mornings call and webcast.

As a reminder, this event is being recorded today, Wednesday, May 7th, 2025.

During today's presentation, all parties will be in a listen-only mode. If you need any assistance during this time, please press star and 0.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on a touchtone phone. To withdraw your question, please press star, then 2.

I would now like to introduce your host, Brian Moore, Vice President of investor relations with Star Surgical. Please go ahead.

---------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.